When COVID-19 set upon the U.S. in March, medtech executives only had a month at most to explain to analysts in quarterly calls how the pandemic was hitting their companies — not nearly enough time to understand the long-term impact. Three more months have passed since those quarterly calls, and we’re now wrapping up a […]
Nuvasive
NuVasive dips despite Street-beating Q2
NuVasive (NSDQ:NUVA) shares closed today on the downturn despite second-quarter results that beat the consensus forecast. The San Diego-based spine surgery technology developer posted losses of -$50 million, or -98¢ per share, on sales of $203.6 million for the three months ended June 30, 2020, for a bottom-line slide from profits of nearly $15 million year-over-year […]
NuVasive projecting losses up to $40m for Q2
NuVasive (NSDQ:NUVA) announced that it anticipates losses for the second quarter to come in around -$40 million amid the COVID-19 pandemic. The San Diego-based spine surgery technology developer said in a news release that preliminary results for the quarter, ended June 30, 2020, revealed an operating loss of between -$35 million and -$40 million on a […]
NuVasive launches pediatric spinal deformity device
NuVasive (NSDQ:NUVA) announced today that it launched its Reline 3D posterior fixation system for pediatric spinal deformities. San Diego-based NuVasive’s latest addition to its spine portfolio is now commercially available around the globe for treating adolescent idiopathic scoliosis (AIS). The Reline 3D is designed to turn a multi-step technique into a holistic, single-plane correction to offer […]
Nuvasive announces $400m offering
NuVasive (NSDQ:NUVA) announced that it intends to offer $400 million aggregate principal amount of convertible senior notes in a private offering. The San Diego-based spine technology company is offering the notes, due in 2023, as well as granting initial purchasers a 13-day option to purchase up to an additional $50 million in notes. According to a […]
NuVasive lands 2 510(k)s, launches spinal surgery device
NuVasive (NSDQ:NUVA) announced that it received FDA 510(k) clearance for its Modulus ALIF and Cohere TLIF-O offerings for thoracolumbar procedures. The San Diego-based company expanded its Advanced Materials Science (AMS) implant portfolio with the clearances, along with the commercial launch of the Modulus extreme lateral interbody fusion (XLIF) dual-sided plate. NuVasive’s Modulus anterior lumbar interbody fusion (ALIF) […]
NuVasive recalls scoliosis treatment devices
NuVasive (NSDQ:NUVA) issued an urgent field safety notice to warn users of an issue with the separation of a certain component in its Magec system model X rods. According to the safety notice, post-implant separation of an actuator end cap component was observed in the rods. Data from post-market surveillance revealed that the end cap separation […]
NuVasive prices $450m offering
NuVasive (NSDQ:NUVA) yesterday announced the pricing of a $450 million offering of convertible senior notes in a private placement. The offering consists of an aggregate principal amount of 0.375% convertible notes due in 2025. The San Diego-based spine technology company also granted initial purchasers a 13-day option to purchase up to an additional $50 million aggregate […]
NuVasive down despite doubled Q4 profits
NuVasive (NSDQ:NUVA) shares are down today despite fourth-quarter results that easily topped the consensus forecast and revealed more than double the profits compared to the same time last year. The San Diego-based spine technology company posted profits of $29.9 million, or 55¢ per share, on sales of $310.4 million for the three months ended Dec. 31, […]
NuVasive appoints new chief financial officer
NuVasive (NSDQ:NUVA) this week announced that it appointed Matthew Harbaugh as executive VP and chief financial officer, effective immediately. Harbaugh replaces Rajesh Asarpota, who is transitioning from the company. He has more than 25 years of experience in finance, business and strategy and operations management. Harbaugh will be responsible for overseeing all financial aspects of the […]
NuVasive gains on beat-n-raise Q3 numbers
NuVasive (NSDQ:NUVA) shares are up today after the spine implant maker reported beat-and-raise third-quarter results. San Diego-based NuVasive posted profits of $11.0 million, or 21¢ per share, on sales of $290.8 million for the three months ended Sept. 30, for a bottom-line slide of -30.9% on revenue growth of 20.2%. Adjusted to exclude one-time items, earnings […]
